NCT05333250 2026-01-13
MODIFY
Ottawa Hospital Research Institute
Phase 1/2 Recruiting
Clinical Trials
26 trialsNCT01781468 2025-01-27
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01330446 2024-02-14
Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT01032200 2021-09-28
Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
Wake Forest University Health Sciences
Phase 2 Completed
NCT01381718 2021-08-13
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
University of South Florida
Phase 2 Completed
NCT00418691 2020-09-23
Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00052286 2020-08-03
Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer
Jonsson Comprehensive Cancer Center
Phase NA Completed
NCT01019187 2020-04-09
Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT01317550 2020-02-10
A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil
M.D. Anderson Cancer Center
Phase NA Completed
NCT01011218 2018-11-29
Management of Insomnia in Breast Cancer Patients
Stanford University
Phase 2 Completed
NCT01746043 2018-06-06
A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00267332 2018-05-07
Modafinil in Opioid Induced Sedation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 3 Terminated
NCT01091974 2017-02-09
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
University of Rochester
Phase 2 Completed
NCT00766467 2016-07-28
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00178373 2015-12-23
Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer
University of Rochester
Phase 2 Completed
NCT01169753 2015-12-08
Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients
M.D. Anderson Cancer Center
Phase NA Terminated
NCT00042848 2015-10-15
Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer
University of Rochester
Phase 3 Completed
NCT02385656 2015-03-11
The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study
Seoul National University Bundang Hospital
Phase 4 Unknown
NCT01048983 2015-03-05
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT01219673 2015-02-10
Symptom Burden in Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT01348607 2014-02-21
Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy
University of South Florida
Phase 2 Terminated
NCT01400958 2013-12-16
Nuvigil or Placebo in Newly Diagnosed Malignant Glioma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT00829322 2013-08-19
Modafinil for the Treatment of Fatigue in Lung Cancer V9.0
University of Oxford
Phase 4 Completed
NCT01044004 2013-07-23
Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue
Washington University School of Medicine
Phase NA Withdrawn
NCT01766323 2013-01-11
Palliative Morphine With or Without Concurrent Modafinil
Dr. Rajendra Prasad Government Medical College
Phase 3 Unknown
NCT01440621 2012-03-23
ModCRF
Indira Gandhi Medical College, Shimla
Phase 3 Completed